Medidata Solutions, a Dassault Systèmes company, has achieved significant recognition in the 2024 Pharmaceutical Technology Excellence Awards, securing victories in both Innovation and Product Launches categories for its cutting-edge digital solutions in clinical trial management.
Revolutionary EHR Integration Platform
Health Record Connect, Medidata's award-winning interoperability engine, represents a breakthrough in clinical trial data management. The platform creates seamless bridges between clinical research and healthcare data systems, enabling secure acquisition and transformation of electronic health records across organizations. This innovation eliminates the traditional complexity of site-by-site integrations and data transfer agreements, significantly accelerating the clinical trial process.
The solution's immediate operability has transformed Electronic Data Capture (EDC) form completion by leveraging existing patient health record data, substantially reducing manual data entry requirements that have historically burdened clinical research teams.
AI-Powered Data Management Transformation
In parallel, Medidata's Clinical Data Studio has revolutionized clinical research data management through its unified platform approach. The solution integrates diverse data sources and employs artificial intelligence to enhance data quality and streamline workflows, earning recognition in the Product Launches category.
The platform's impact on operational efficiency is remarkable, demonstrating up to 80% reduction in data review and reconciliation times, alongside a 50% decrease in patient profile review duration. These improvements are achieved through an intuitive no/low code environment that simplifies data aggregation and standardization processes.
Advanced Quality Management Features
Clinical Data Studio's capabilities extend beyond basic data management, incorporating sophisticated tools such as Medidata Data Surveillance and Data Quality Management. These features support a comprehensive approach to risk-based quality management (RBQM), ensuring robust data integrity throughout the clinical trial process.
Track Record of Innovation
With a 25-year history of technological advancement, Medidata has established itself as a cornerstone in clinical research technology. The company's platform currently supports more than 34,000 trials and 10 million patients, serving approximately 2,200 customers through its one million registered users.
The platform's comprehensive capabilities have earned Medidata recognition as an industry leader by both Everest Group and IDC, reflecting its significant contribution to accelerating clinical breakthroughs and improving patient experiences in therapeutic development.
